38例隐睾精原细胞瘤临床分析

Clinical Analysis of 38 Cases with Testicond Seminoma

我院1975年3月至1987年12月收治隐睾发生的精原细胞瘤38例，占同期睾丸精原细胞瘤35．1％（38／109），Ⅰ期18例、Ⅱ期9例、ⅡB期8例、Ⅲ期2例、Ⅳ期1例。其中腹股为隐睾精原细胞癌Ⅰ期10例，占55．5％．Ⅱ期6例占33．3％，Ⅲ、Ⅳ期各1例。腹腔隐睾精原细胞瘤Ⅰ期8例占40％，Ⅱ期11例占55％，Ⅲ期1例。放疗为主要治疗手段，少数中晚期合并用N-甲基溶肉瘤素化疗。5年及10年生存率分别为89．5％和84．2％，Ⅰ期的5、10年生存率为100％，Ⅱ期分别为88．2％和82．4％，Ⅲ期生存率为50％。

From March 1975 to December 1987,38 patients with testicond seminoma occupied 35. 1 % of testicular seminoma during the same period. Among 38 cases, 18 cases were in stage 1, 9 cases were in stage Ⅱ A, 8 cases were in stage ⅡB, 2 cases were in stage, and one case was in stage W. Total of 18 cases were inguinal testicond seminorna.among them, 10 cases were in stage I (55. 5 % ), 6 cases were in stage Ⅱ (33. 3% ) ; 2 cases were in stage, and stage respectively. The rest were testicond seminoma in abdomina,atnong them, 8 cases were in stage 1 (40 % ), 11 cases were in stage Ⅱ (55 % ),and one case was in stage Ⅲ. Radiotherapy was main theIapeutic method .a few pa-tients with advanced diseases were also given N-mytbioration except radiotherapy. The results show 5 years and 1O years survival rates are 89.5 % and 84. 2% respectively. 10 years survival rate in stage is 100%. 5 years and 10 years survival rates in stage Ⅱ are 88. 2 % and 82. 4%respeively. 5 yders sutwval rate in stage Ⅲ is 50%.